{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-018884","form_type":"8-K","ticker":"PRI","cik":"0001475922","company_name":"Primerica, Inc.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.978790+00:00","generated_at":"2026-06-15T12:46:43.367317+00:00","sec_items":["2.02","9.01","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Primerica Q1 net EPS $3.38, up 16%; term life face amount +14% to $28.1B","bullets":["Net income $125.1M (+9%); diluted EPS $3.38 (+16%); adjusted EPS $3.49 (+18%).","Term life face amount issued $28.1B (+14% YoY); life-licensed sales force up 5% to 136,430.","ISP revenues $210.2M (-13%); sales down 25%; positive net flows $642M.","Senior Health segment loss narrowed to $3.8M from $19.0M on improved profitability.","Declared dividend $0.65/share payable June 12; repurchased $85M of stock in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-018884","json":"https://secwatch.observer/filing/0000950170-23-018884.json","markdown":"https://secwatch.observer/filing/0000950170-23-018884.md","text":"https://secwatch.observer/filing/0000950170-23-018884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1475922/000095017023018884/0000950170-23-018884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1475922/000095017023018884/pri-20230508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T12:46:43.367317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14c38d835992cef3a9e3559bf648c6e622961274","claim":"Primerica, Inc. reported the quarter ended March 31, 2023 results: revenue $690.0 million, net income $125.1 million, EPS $3.38 per diluted share.","evidence_excerpt":"Primerica, Inc. (NYSE: PRI) today announced financial results for the quarter ended March 31, 2023. Total revenues of $690.0 million were largely unchanged compared to the first quarter of 2022. Net income attributable to Primerica of $125.1 million increased 9%, while earnings per diluted share of $3.38 increased 16% compared to the same period in the prior year. ROE was 25.5% for the quarter. Adjusted operating revenues of $695.0 million were relatively unchanged compared to the first quarter of 2022. Adjusted net operating income of $128.9 million increased 10%, while adjusted operating earnings per diluted share of $3.49 increased 18% compared to the same period in the prior year. ROAE was 24.2% for the quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1475922/000095017023018884/0000950170-23-018884-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$690.0 million"},{"label":"Net income","value":"$125.1 million"},{"label":"EPS","value":"$3.38 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}